Meet Our Team of Experts

Biolytica Experts

Management Team

A serial investor and entrepreneur who started his first company straight out of college, Jörg – after only three years – successfully excited that company. Following his passion to build companies that make an impact, Jörg established – amongst other companies – a leading European IT asset management strategy consultancy which he sold to one of the BIG4, whereupon he served as Global Lead Partner for a further four years. Jörg has, since then, invested in more than 25 start-up and mid-sized companies, with nine out of ten of the start-ups becoming successful (including two IPOs and 1 Unicorn). Shown to be a good hand in building and investing in companies, Jörg is a member of selected Advisory Boards and teaches Entrepreneurship and Innovation at a leading university in Germany.

Jörg Rieker

President of the Board


Marc P. Bernegger is a serial-tech entrepreneur who has been following developments in the field of longevity since 2009. Besides co-founding the longevity company-builder Maximon and the Longevity Investors Conference, he is involved in the crypto hedge fund AltAlpha Digital and is among others in the board of CfC St. Moritz and the Swiss Blockchain Federation. Marc explored Bitcoin in 2012 and was a founding shareholder and board member of Crypto Finance Group (acquired by Deutsche Boerse in 2021). Marc started his entrepreneurial journey by founding the party platform right after college (acquired by Axel Springer Media). He is also a co-founder of amiando, a ticketing platform, which was purchased by Xing and named “Global Technology Pioneer” by the World Economic Forum (WEF). Marc holds a master’s degree in law from the University of Zurich and is an alumni of the Singularity University. 

Marc P. Bernegger

Member of the Board

With an extensive background as a hands-on programmer and architect – and in the leading of international teams – Dan brings decades of experience in building and supporting software solutions across several diverse industries. With two software patents and several published technical papers under his belt, he continues to strive towards finding unique ways to approach any challenge. When Dan’s father was diagnosed with cancer – and a colleague shortly thereafter – he worked towards a solution that integrated medical records, wearable devices, and genomics to improve treatments in these areas. Dan also holds a Master of Science in Computer Science and – as an early adopter of wearable technologies – has been tracking his own personal data for almost ten years.

Dan Fobes

Co-Founder and CTO

With over 24 years of clinical and entrepreneurial  experience, Carron brings together expertise in musculoskeletal and sports physiotherapy, Pilates, and Functional Medicine Health coaching, in addition to an understanding of how clinical practice works. Her holistic approach and understanding of clinical practice enable her to understand the  clients needs and to accompany and assist B2B and B2C clients to achieve the success they strive for.

Carron Howard

Head of Partnership Management

After five years of work in the laboratory, Doris decided to contribute to longevity research by joining Biolytica. She brings a scientific perspective as a biologist with practical experience in aging and rejuvenation research. In the position of Scientific Curator, she contributes to the collection, processing, and organization of large datasets, as well as staying updated with the latest scientific advancements in the field of longevity. Her personal belief in the importance and potential of longevity is aligned with the data-driven and science-based approach at Biolytica

Doris is also soon to complete her doctoral studies in the field of sleep medicine. Through continuous learning and development, she aims to assist Biolytica in delivering the best scientific expertise.

Doris Plećaš

Project Lead Clinical Programs

Biolytica Experts

Advisory Board

President EMEA, Thermo Fischer. Former Global Head of Healthcare at Linde Group. Foundation Medicine, Chiron, ImmuCor, Relia Diagnostics. Urmi joined Thermo Fisher Scientific in June 2021 as President of EMEA. Her focus is to provide an enterprise view of Thermo Fisher’s value proposition whilst driving sustainable growth. She has 25+ years of global experience in biotech, biopharma and healthcare, including senior positions at Roche, Novartis, Immucor, Chiron and G.D. Searle. Urmi has industry experience in molecular diagnostics, cancer genomics, infectious diseases, point of care and medical devices, clinical laboratory testing and respiratory care. She has leadership experience delivering results with global cross-functional teams in strategic planning, business development, portfolio commercialization and new market expansion throughout EMEA, Asia, and South America. She has also worked extensively with governments and policy organizations to drive sustainable growth in emerging markets. Having studied and worked in over half a dozen countries, these experiences strengthen her ability to demonstrates reliable and visible leadership in transformational times, embracing cultural evolution to build alliances and mobilize partners for success. Urmi has an MBA from Thunderbird School of Global Management, an MS in Biochemical Engineering from the University of Houston, a BA in Biology and French from Rutgers University, and an International Baccalaureate Diploma from the American School of Paris. She is fluent in English, French and Hindi, and is dinner party ready in Spanish, German and Bengali.

Urmi Prasad Richardson

Advisory Board Member

Patrick Vogler is a Business Economist with a MAS in Corporate Finance and degree in Business Law. He is a Swiss Certified Accountant and holds a degree in hospitality (General Manager Programm) from Cornell University, Ithaca, New York.
Patrick is an experienced CEO and CFO. He is a member of various Board of Directors, Advisory Boards as well as Board of Trustees in Switzerland and is Managing Director of Patrick Vogler Advisory Ltd. In addition he acts as a guest lecturer at the university of applied sciences Graubünden, Switzerland. He has an established and broad network in hospitality and also Swiss politics. Patrick was, most recently, first CFO and then CEO of Grand Resort Bad Ragaz Ltd. – an internationally acclaimed 5 star luxury resort and clinic (leading wellbeing & medical health resort in Europe), focussed on personalised health-care programs, in-patient rehabilitation, in addition to offering world class Michelin star gastronomy and luxury accommodation.
Patrick has successfully repositioned and rebranded numerous businesses. He has developed innovative tools and apps to improve customer experience and employee engagement. In addition he implemented sustainability concepts and strategies into the Grand Resort Bad Ragaz Group. He has extensive experience in leading an IT department, implementing new ERP systems and merging IT systems as part of digitization strategies.
His strengths of multicultural understanding, and team orientated leadership style combined with his extensive experience in finance, family and publicly owned companies, hospitality, hotels, wellness, and personalised health care make him an invaluable Advisory Board Member to Biolytica.

Patrick Vogler

Advisory Board Member

Martin is a transformation architect and enrich the strategic movers and shakers of his clients with his experience in operational excellence enabled by technology. He strongly believes in the powerful combination of machines and people and he is passionate about new technologies and longevity, and about creating a better world for the new generations. His industry focus is the consumer retail, consumer health and life sciences industry.

Martin has over 20 years experience leading large transformation programs for multinational companies, with a particular focus on Customer Centricity and AI Experience in the real world as well as in the metaverse. He worked mainly for consulting companies most recently being a Partner in McKinsey and EY. He has successfully supported 50+ clients designing and deploying their AI & Automation projects with the aim of reducing cost, increasing revenue, and managing risk.

He is involved in driving the technology agenda for corporate clients as well as in building out its attacker businesses to disrupt classical business models. He has helped software start-ups and private equity investors in various stages in scaling their business models or growing their investments.

He is currently serving as an advisory board member of Biolytica and is appointed to the permanent role of the Managing Partner of Infosys Consulting in Switzerland.

Martin Weis

Advisory Board Member

Re-Thinking Health.

Biolytica is dedicated to advancing health and longevity through the development of cutting-edge technologies and innovative strategies. We empower individuals by providing them with a deeper understanding of their health and collaborate with health and longevity facilities to deliver unparalleled personalized experiences for their clients.